TTN and myasthenia gravis: The presence of anti-Titin autoantibodies is a distinctive feature of late-onset (>50 years) myasthenia gravis, with nearly 50% of patients diagnosed with late-onset myasthenia gravis having detectable anti-Titin autoantibodies, while anti-Titin autoantibodies are rare in patients with early-onset disease (84).